Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76dd75c94c-5fx6p Total loading time: 0 Render date: 2024-04-30T08:22:43.488Z Has data issue: false hasContentIssue false

Chapter 15 - Peripheral Artery Disease

from Section III - Care of the Elderly by Organ System

Published online by Cambridge University Press:  30 June 2022

By
Rachelle Hamadi  and
Casey N. Rust
Edited by
Jan Busby-Whitehead ,
Samuel C. Durso ,
Christine Arenson ,
Rebecca Elon ,
Mary H. Palmer  and
William Reichel
Jan Busby-Whitehead
Affiliation:
University of North Carolina, Chapel Hill
Samuel C. Durso
Affiliation:
The Johns Hopkins University, Maryland
Christine Arenson
Affiliation:
Thomas Jefferson University, Philadelphia
Rebecca Elon
Affiliation:
The Johns Hopkins University School of Medicine
Mary H. Palmer
Affiliation:
University of North Carolina, Chapel Hill
William Reichel
Affiliation:
Georgetown University Medical Center
Get access

Summary

This chapter gives an overview of the pathophysiology, prevalence, risk factors, and symptoms of peripheral artery disease (PAD). The subsequent screening, diagnosis, and management of PAD are further elucidated. The chapter specifically emphasizes the prevalence of PAD in the elderly and the impact of disease. PAD results from the obstruction of peripheral arteries, leading to a reduction in blood flow to the extremities. PAD may be asymptomatic or lead to a variety of symptoms including claudication, chronic skin discoloration, hair loss, non-healing ulcers, and infections. PAD prevalence increases with increasing age, thus elderly patients should be routinely evaluated for symptoms of extremity pain and non-healing wounds. An ankle-brachial index (ABI) of less than 0.9 is diagnostic for PAD. Treatments for PAD may include the management of medical comorbidities, exercise, smoking cessation, medications such as antiplatelets and vasodilators, and surgical interventions. Early intervention can prevent limb ischemia and ultimately limb loss.

Keywords

peripheral artery diseaseatherosclerosisclaudicationankle-brachial indexlimb ischemia
Type
Chapter
Information
Reichel's Care of the Elderly
Clinical Aspects of Aging
 , pp. 180 - 188
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hirsch, AT, Hiatt, WR. PAD Awareness, risk, and treatment: New resources for survival – the USA PARTNERS program. Vasc Med. 2001; 6:9–12.CrossRefGoogle ScholarPubMed
Fowkes, FGR, Rudan, D, Rudan, I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet. 2013; 382:1329–1340.Google Scholar
Schramm, K, Rochon, PJ. Gender differences in peripheral vascular disease. Semin Intervent Radiol. 2018; 35(1):9–16.Google Scholar
Gerhard-Herman, MD, Gornik, HL, Barrett, C, et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: Executive summary. Vasc Med. 2017; 22(3):NP1–NP43.Google ScholarPubMed
Carmelli, D, Fabsitz, RR, Swan, GE, Reed, T, Miller, B, Wolf, PA. Contribution of genetic and environmental influences to ankle-brachial blood pressure index in the NHLBI Twin Study. Am J Epidemiol. 2000; 151:452.Google Scholar
Wahlgren, CM, Magnusson, PK. Genetic influences on peripheral arterial disease in a twin population. Anterioscler Thromb Vasc Biol. 2011; 31:678.Google Scholar
Chen, Q, Shi, Y, Wang, Y, Li, X. Patterns of disease distribution of lower extremity peripheral arterial disease. Angiology. 2015; 66(3):211–218.Google Scholar
Norgren, L, Hiatt, WR, Dormandy, JA, Nehler, MR, Harris, KA, Fowkes, FGR. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007; 45:S5.CrossRefGoogle ScholarPubMed
Vainas, T, Stassen, FR, de Graaf, R, et al. C-reactive protein in peripheral arterial disease: Relation to severity of the disease and to future cardiovascular events. J Vasc Surg. 2005; 42(2):243–251.Google Scholar
Ferket, BS, Spronk, S, Colkesen, EB, Hunink, MM. Systematic review of guidelines on peripheral artery disease screening. Am J Med. 2012; 125:198.Google Scholar
Services, UP, Force, T, Curry, SJ, et al. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index: US Preventive Services Task Force Recommendation Statement. JAMA. 2018; 320:177.Google Scholar
Guirguis-Blake, JM, Evans, CV, Redmond, N, Lin, JS. Screening for peripheral artery disease using the ankle-brachial index: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018; 320:184.Google Scholar
McDermott, MM, Greenland, P, Liu, K, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001; 286:1599.Google Scholar
Khan, NA, Rahim, SA, Anand, SS, Simel, DL, Panju, A. Does the clinical examination predict lower extremity peripheral arterial disease? JAMA. 2006; 295:536.Google Scholar
Hirsch, AT, Haskal, ZJ, Hertzer, NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006; 113:e463.Google Scholar
Haigh, KJ, Bingley, J, Golledge, J, Walker, PJ. Barriers to screening and diagnosis of peripheral artery disease by general practitioners. Vasc Med. 2013; 18(6):325–330.Google Scholar
Mills, JLS, Conte, MS, Armstrong, DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014; 59:220.Google Scholar
Morris, DR, Rodriguez, AJ, Moxon, JV, et al. Association of lower extremity performance with cardiovascular and all-cause mortality in patients with peripheral artery disease: A systematic review and meta-analysis. J Am Heart Assoc. 2014; 3:e001105.Google Scholar
Low Wang, CC, Blomster, JI, Heizer, G, et al. Cardiovascular and limb outcomes in patients with diabetes and peripheral artery disease: The EUCLID trial. J Am Coll Cardiol. 2018; 72:3274.Google Scholar
Whelton, PK, Carey, RM, Aronow, WS. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018; 71(19):2177–2188.Google Scholar
SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373:2103–2116.Google Scholar
Willigendael, EM, Teijink, JA, Bartelink, ML, et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg. 2004; 40:1158.Google Scholar
Lane, R, Harwood, A, Watson, L, Leng, GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017; 12:CD000990.Google Scholar
Garg, PK, Tian, L, Criqui, MH. Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation. 2006; 114:242.Google Scholar
Watson, L, Ellis, B, Leng, GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008:CD000990.Google Scholar
Vemulapalli, S, Dolor, RJ, Hasselblad, V, et al. Supervised vs unsupervised exercise for intermittent claudication: A systematic review and meta-analysis. Am Heart J. 2015; 169:924.Google Scholar
Mazari, FAK, Khan, JA, Carradice, D, et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. Br J Surg. 2012; 99:39.Google Scholar
Nylaende, M, Abdelnoor, M, Stranden, E, et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT): The 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2007; 33:3.CrossRefGoogle ScholarPubMed
Conte, MS, Pomposelli, FB, Clair, DG, et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. J Vasc Surg. 2015; 61:2S.CrossRefGoogle ScholarPubMed
Morrow, DA, Braunwald, E, Bonaca, MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012; 366:1404.Google Scholar
Thompson, PD, Zimet, R, Forbes, WP, Zhang, P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol. 2002; 90:1314.CrossRefGoogle ScholarPubMed
Pande, RL, Hiatt, WR, Zhang, P, Hittel, N, Creager, MA. A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med. 2010; 15:181.Google Scholar
Beebe, HG, Dawson, DL, Cutler, BS, et al. A new pharmacological treatment for intermittent claudication: Results of a randomized, multicenter trial. Arch Intern Med. 1999; 159(17):2041.Google Scholar
O’Donnell, ME, Badger, SA, Sharif, MA, Young, IS, Lee, B, Soong, CV. The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease. J Vasc Surg. 2009; 49:1226.Google Scholar
Gardner, AW, Afaq, A. Management of lower extremity peripheral arterial disease. J Cardiopulm Rehabil Prev. 2008; 28(6):349–357.CrossRefGoogle ScholarPubMed
Rooke, TW, Hirsch, AT, Misra, S, et al. ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline). J Am Coll Cardiol. 2011; 58(19):2020–2045.CrossRefGoogle ScholarPubMed
Lewis, SR, Pritchard, MW, Schofield‐Robinson, OJ, Alderson, P, Smith, AF. Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2018; 7:CD012584.Google ScholarPubMed
Devereaux, PJ, Mrkobrada, M, Sessler, DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014; 370:1494.Google Scholar
Biccard, BM, Sigamani, A, Chan, MTV, et al. Effect of aspirin in vascular surgery in patients from a randomized clinical trial (POISE‐2). Br J Surg. 2018; 105:1591.Google Scholar
Goodney, PP, Schanzer, A, DeMartino, RR, et al. Validation of the Society for Vascular Surgery’s objective performance goals for critical limb ischemia in everyday vascular surgery practice. J Vasc Surg. 2011; 54:100.Google Scholar
Leithead, C, Novak, Z, Spangler, E, et al. Importance of postprocedural wound, ischemia, and foot infection (WIfI) restaging in predicting limb salvage. J Vasc Surg. 2018; 67:498.Google Scholar
Stoner, MC, Calligaro, KD, Chaer, RA, et al. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg. 2016; 64:e1.CrossRefGoogle Scholar
Albäck, A, Biancari, F, Schmidt, S, et al. Haemodynamic results of femoropopliteal percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg. 1998; 16:7.CrossRefGoogle ScholarPubMed
Criqui, MH, Langer, RD, Fronek, A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992; 326:381.Google Scholar
Teraa, M, Conte, MS, Moll, FL, Verhaar, MC. Critical limb ischemia: Current trends and future directions. J Am Heart Assoc. 2016; 5:e002938.Google Scholar
Welten, GM, Schouten, O, Hoeks, SE, et al. Long-term prognosis of patients with peripheral arterial disease: A comparison in patients with coronary artery disease. J Am Coll Cardiol. 2008; 51:1588.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×